In Vivo Toxicology Market: Growth, Analysis & Key Players
The in vivo toxicology market is poised for important expansion, projected to reach $6.6 billion by 2025. Fuelled by advancements in pharmaceutical R&D, personalized medicine, and the rise of sophisticated animal models, this sector is witnessing robust growth. Immunotoxicity testing and chronic testing types are leading the charge, with outsourced facilities dominating the landscape. North America currently leads in market share,driven by significant biomedical research. News Directory 3 understands the dynamics of this evolving market. Explore the latest trends and uncover what innovations will shape the future of in vivo toxicology.
In Vivo Toxicology Market Growth Driven by Research and Innovation
The global in vivo toxicology market is anticipated to expand from $5 billion in 2020 to $6.6 billion by 2025, reflecting a compound annual growth rate (CAGR) of 5.5%. Increased pharmaceutical research and progress, advancements in animal models, and the rising need for personalized medicine are key factors propelling this growth.
Humanized animal models are increasingly vital for preclinical studies, offering insights into human biology through the engraftment of human cells or tissues. These models, particularly humanized mice, find applications in cancer research, infectious diseases, and regenerative medicine. The National Institute of Allergy and Infectious Diseases (NIAID) supports projects focused on the development and comparison of humanized immune system (HIS) mouse models.
Immunotoxicity testing held the largest market share in 2019, driven by the rising demand for biologics and biosimilars. Chronic test types are also expected to see significant growth due to increased research on long-duration therapies. Outsourced testing facilities currently dominate the market, attributed to cost-saving strategies and increased R&D investments by pharmaceutical and biopharmaceutical companies.
North America held the largest share of the in vivo toxicology market in 2019, due to the presence of major industry players and growing biomedical research activities.
What’s next
Continued innovation in animal models and a sustained focus on personalized medicine are expected to further drive the expansion of the in vivo toxicology market in the coming years.